Esther Larrea

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Gardiquimod Nanoemulsion Targets Cutaneous Leishmaniasis Lesions Reducing Systemic Toxicity and Parasite Burden.

Gardiquimod Nanoemulsion Targets Cutaneous Leishmaniasis Lesions Reducing Systemic Toxicity and Parasite Burden.

Journal: Advanced healthcare materials

Published: January 05, 2026

Leishmanicidal Action of the Peptides 19-4LF, 19-2.5 and 19-2.5LF Topically Administered on Cutaneous Lesions Caused by Leishmania major.

Leishmanicidal Action of the Peptides 19-4LF, 19-2.5 and 19-2.5LF Topically Administered on Cutaneous Lesions Caused by Leishmania major.

Journal: Pharmaceutics

Published: December 25, 2025

Fluidity as a key determinant of stability in PEGylated lipid nanoparticles loaded with a TLR7 agonist.

Fluidity as a key determinant of stability in PEGylated lipid nanoparticles loaded with a TLR7 agonist.

Journal: International journal of pharmaceutics

Published: August 27, 2025

The Role of BRCT Domain from LmjPES in Leishmania major Pathogenesis.

The Role of BRCT Domain from LmjPES in Leishmania major Pathogenesis.

Journal: Biomolecules

Published: July 10, 2025

Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis.

Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis.

Journal: Pharmaceutics

Published: October 19, 2022

The BRCT Domain from the Homologue of the Oncogene PES1 in Leishmania major (LmjPES) Promotes Malignancy and Drug Resistance in Mammalian Cells.

The BRCT Domain from the Homologue of the Oncogene PES1 in Leishmania major (LmjPES) Promotes Malignancy and Drug Resistance in Mammalian Cells.

Journal: International journal of molecular sciences

Published: September 23, 2022

Changes in the nanoparticle uptake and distribution caused by an intramacrophagic parasitic infection.

Changes in the nanoparticle uptake and distribution caused by an intramacrophagic parasitic infection.

Journal: Nanoscale

Published: October 15, 2021

In Leishmania major, the Homolog of the Oncogene PES1 May Play a Critical Role in Parasite Infectivity.

In Leishmania major, the Homolog of the Oncogene PES1 May Play a Critical Role in Parasite Infectivity.

Journal: International journal of molecular sciences

Published: September 30, 2021

Effect of topical berberine in murine cutaneous leishmaniasis lesions.

Effect of topical berberine in murine cutaneous leishmaniasis lesions.

Journal: The Journal of antimicrobial chemotherapy

Published: June 03, 2021

LmjF.22.0810 from Leishmania major Modulates the Th2-Type Immune Response and Is Involved in Leishmaniasis Outcome.

LmjF.22.0810 from Leishmania major Modulates the Th2-Type Immune Response and Is Involved in Leishmaniasis Outcome.

Journal: Biomedicines

Published: September 13, 2020

Berberine-Loaded Liposomes for the Treatment of Leishmania infantum-Infected BALB/c Mice.

Berberine-Loaded Liposomes for the Treatment of Leishmania infantum-Infected BALB/c Mice.

Journal: Pharmaceutics

Published: July 24, 2020

The Novel Serine/Threonine Protein Kinase LmjF.22.0810 from Leishmania major may be Involved in the Resistance to Drugs such as Paromomycin.

The Novel Serine/Threonine Protein Kinase LmjF.22.0810 from Leishmania major may be Involved in the Resistance to Drugs such as Paromomycin.

Journal: Biomolecules

Published: October 06, 2019

Showing 1-12 of 35

Last Updated: 09/26/2026